Selected research
Industry Research
Clinical Trials Outsourcing Industry Research Report 2026
Market perspective
The global Clinical Trials Outsourcing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Clinical Trials Outsourcing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Clinical Trials Outsourcing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Clinical Trials Outsourcing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Clinical Trials Outsourcing include Charles River Laboratories, IQVIA, ICON PLC, Labcorp Drug Development, Syneos Health, Thermo Fisher Scientific, Wuxi AppTec, Parexel and Advanced Clinical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Clinical Trials Outsourcing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Clinical Trials Outsourcing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Clinical Trials Outsourcing Market by Company
Charles River Laboratories
IQVIA
ICON PLC
Labcorp Drug Development
Syneos Health
Thermo Fisher Scientific
Wuxi AppTec
Parexel
Advanced Clinical
BioAnalytix
Curia Global
CMED
Cromos Pharma
Criterium
KCR S.A.
Medpace
Medelis
OCT Group
ProTrials Research
PROMETRIKA
Quality Data Service
QPS
Sofpromed
Veristat
Worldwide Clinical Trials
Clinical Trials Outsourcing Segment by Type
Phase I
Phase II
Phase III
Phase IV
Clinical Trials Outsourcing Segment by Application
Cancer
CVDs
Infectious Diseases
Musculoskeletal Diseases
Nervous System Disorders
Others
Clinical Trials Outsourcing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trials Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trials Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trials Outsourcing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Clinical Trials Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Clinical Trials Outsourcing Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Clinical Trials Outsourcing Revenue Market Share by Type (2021-2026)
Table 7. Global Clinical Trials Outsourcing Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Clinical Trials Outsourcing Revenue Market Share by Type (2027-2032)
Table 9. Global Clinical Trials Outsourcing Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Clinical Trials Outsourcing Revenue Market Share by Application (2021-2026)
Table 11. Global Clinical Trials Outsourcing Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Clinical Trials Outsourcing Revenue Market Share by Application (2027-2032)
Table 13. Global Clinical Trials Outsourcing Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Clinical Trials Outsourcing Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Clinical Trials Outsourcing Market Share by Region (2021-2026)
Table 16. Global Clinical Trials Outsourcing Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Clinical Trials Outsourcing Market Share by Region (2027-2032)
Table 18. Clinical Trials Outsourcing Industry Trends
Table 19. Clinical Trials Outsourcing Industry Drivers
Table 20. Clinical Trials Outsourcing Industry Opportunities and Challenges
Table 21. Clinical Trials Outsourcing Market Restraints
Table 22. Global Top Clinical Trials Outsourcing Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Clinical Trials Outsourcing Revenue Market Share by Players (2021-2026)
Table 24. Global Clinical Trials Outsourcing Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Clinical Trials Outsourcing, Headquarters and Area Served
Table 26. Global Clinical Trials Outsourcing Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Clinical Trials Outsourcing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Clinical Trials Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Clinical Trials Outsourcing Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Clinical Trials Outsourcing Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Clinical Trials Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Clinical Trials Outsourcing Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Clinical Trials Outsourcing Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Clinical Trials Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Clinical Trials Outsourcing Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Clinical Trials Outsourcing Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Clinical Trials Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Clinical Trials Outsourcing Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Clinical Trials Outsourcing Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Clinical Trials Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Clinical Trials Outsourcing Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Clinical Trials Outsourcing Market Size by Country (2027-2032) & (US$ Million)
Table 45. Charles River Laboratories Company Information
Table 46. Charles River Laboratories Business Overview
Table 47. Charles River Laboratories Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 48. Charles River Laboratories Clinical Trials Outsourcing Product Portfolio
Table 49. Charles River Laboratories Recent Developments
Table 50. IQVIA Company Information
Table 51. IQVIA Business Overview
Table 52. IQVIA Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 53. IQVIA Clinical Trials Outsourcing Product Portfolio
Table 54. IQVIA Recent Developments
Table 55. ICON PLC Company Information
Table 56. ICON PLC Business Overview
Table 57. ICON PLC Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 58. ICON PLC Clinical Trials Outsourcing Product Portfolio
Table 59. ICON PLC Recent Developments
Table 60. Labcorp Drug Development Company Information
Table 61. Labcorp Drug Development Business Overview
Table 62. Labcorp Drug Development Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 63. Labcorp Drug Development Clinical Trials Outsourcing Product Portfolio
Table 64. Labcorp Drug Development Recent Developments
Table 65. Syneos Health Company Information
Table 66. Syneos Health Business Overview
Table 67. Syneos Health Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 68. Syneos Health Clinical Trials Outsourcing Product Portfolio
Table 69. Syneos Health Recent Developments
Table 70. Thermo Fisher Scientific Company Information
Table 71. Thermo Fisher Scientific Business Overview
Table 72. Thermo Fisher Scientific Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 73. Thermo Fisher Scientific Clinical Trials Outsourcing Product Portfolio
Table 74. Thermo Fisher Scientific Recent Developments
Table 75. Wuxi AppTec Company Information
Table 76. Wuxi AppTec Business Overview
Table 77. Wuxi AppTec Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 78. Wuxi AppTec Clinical Trials Outsourcing Product Portfolio
Table 79. Wuxi AppTec Recent Developments
Table 80. Parexel Company Information
Table 81. Parexel Business Overview
Table 82. Parexel Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 83. Parexel Clinical Trials Outsourcing Product Portfolio
Table 84. Parexel Recent Developments
Table 85. Advanced Clinical Company Information
Table 86. Advanced Clinical Business Overview
Table 87. Advanced Clinical Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 88. Advanced Clinical Clinical Trials Outsourcing Product Portfolio
Table 89. Advanced Clinical Recent Developments
Table 90. BioAnalytix Company Information
Table 91. BioAnalytix Business Overview
Table 92. BioAnalytix Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 93. BioAnalytix Clinical Trials Outsourcing Product Portfolio
Table 94. BioAnalytix Recent Developments
Table 95. Curia Global Company Information
Table 96. Curia Global Business Overview
Table 97. Curia Global Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 98. Curia Global Clinical Trials Outsourcing Product Portfolio
Table 99. Curia Global Recent Developments
Table 100. CMED Company Information
Table 101. CMED Business Overview
Table 102. CMED Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 103. CMED Clinical Trials Outsourcing Product Portfolio
Table 104. CMED Recent Developments
Table 105. Cromos Pharma Company Information
Table 106. Cromos Pharma Business Overview
Table 107. Cromos Pharma Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 108. Cromos Pharma Clinical Trials Outsourcing Product Portfolio
Table 109. Cromos Pharma Recent Developments
Table 110. Criterium Company Information
Table 111. Criterium Business Overview
Table 112. Criterium Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 113. Criterium Clinical Trials Outsourcing Product Portfolio
Table 114. Criterium Recent Developments
Table 115. KCR S.A. Company Information
Table 116. KCR S.A. Business Overview
Table 117. KCR S.A. Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 118. KCR S.A. Clinical Trials Outsourcing Product Portfolio
Table 119. KCR S.A. Recent Developments
Table 120. Medpace Company Information
Table 121. Medpace Business Overview
Table 122. Medpace Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 123. Medpace Clinical Trials Outsourcing Product Portfolio
Table 124. Medpace Recent Developments
Table 125. Medelis Company Information
Table 126. Medelis Business Overview
Table 127. Medelis Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 128. Medelis Clinical Trials Outsourcing Product Portfolio
Table 129. Medelis Recent Developments
Table 130. OCT Group Company Information
Table 131. OCT Group Business Overview
Table 132. OCT Group Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 133. OCT Group Clinical Trials Outsourcing Product Portfolio
Table 134. OCT Group Recent Developments
Table 135. ProTrials Research Company Information
Table 136. ProTrials Research Business Overview
Table 137. ProTrials Research Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 138. ProTrials Research Clinical Trials Outsourcing Product Portfolio
Table 139. ProTrials Research Recent Developments
Table 140. PROMETRIKA Company Information
Table 141. PROMETRIKA Business Overview
Table 142. PROMETRIKA Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 143. PROMETRIKA Clinical Trials Outsourcing Product Portfolio
Table 144. PROMETRIKA Recent Developments
Table 145. Quality Data Service Company Information
Table 146. Quality Data Service Business Overview
Table 147. Quality Data Service Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 148. Quality Data Service Clinical Trials Outsourcing Product Portfolio
Table 149. Quality Data Service Recent Developments
Table 150. QPS Company Information
Table 151. QPS Business Overview
Table 152. QPS Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 153. QPS Clinical Trials Outsourcing Product Portfolio
Table 154. QPS Recent Developments
Table 155. Sofpromed Company Information
Table 156. Sofpromed Business Overview
Table 157. Sofpromed Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 158. Sofpromed Clinical Trials Outsourcing Product Portfolio
Table 159. Sofpromed Recent Developments
Table 160. Veristat Company Information
Table 161. Veristat Business Overview
Table 162. Veristat Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 163. Veristat Clinical Trials Outsourcing Product Portfolio
Table 164. Veristat Recent Developments
Table 165. Worldwide Clinical Trials Company Information
Table 166. Worldwide Clinical Trials Business Overview
Table 167. Worldwide Clinical Trials Revenue in Clinical Trials Outsourcing Business (2021-2026) & (US$ Million)
Table 168. Worldwide Clinical Trials Clinical Trials Outsourcing Product Portfolio
Table 169. Worldwide Clinical Trials Recent Developments
Table 170. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Clinical Trials Outsourcing Product Image
Figure 5. Global Clinical Trials Outsourcing Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Clinical Trials Outsourcing Market Share by Type: 2025 VS 2032
Figure 7. Phase I Product
Figure 8. Phase II Product
Figure 9. Phase III Product
Figure 10. Phase IV Product
Figure 11. Global Clinical Trials Outsourcing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Clinical Trials Outsourcing Market Share by Application: 2025 VS 2032
Figure 13. Cancer Product
Figure 14. CVDs Product
Figure 15. Infectious Diseases Product
Figure 16. Musculoskeletal Diseases Product
Figure 17. Nervous System Disorders Product
Figure 18. Others Product
Figure 19. Global Clinical Trials Outsourcing Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 20. Global Clinical Trials Outsourcing Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 21. Global Clinical Trials Outsourcing Market Share by Region: 2025 VS 2032
Figure 22. Global Clinical Trials Outsourcing Market Share by Players in 2025
Figure 23. Global Clinical Trials Outsourcing Manufacturers Established Date
Figure 24. Global Top 5 and 10 Clinical Trials Outsourcing Players Market Share by Revenue in 2025
Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 26. North America Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. North America Clinical Trials Outsourcing Market Share by Country (2021-2032)
Figure 28. United States Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Canada Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Mexico Clinical Trials Outsourcing Market Share by Country (2021-2032)
Figure 31. Europe Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Europe Clinical Trials Outsourcing Market Share by Country (2021-2032)
Figure 33. Germany Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. France Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. U.K. Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Italy Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Spain Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Russia Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Netherlands Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Nordic Countries Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Asia-Pacific Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Asia-Pacific Clinical Trials Outsourcing Market Share by Country (2021-2032)
Figure 43. China Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. Japan Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. South Korea Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. India Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. India Clinical Trials Outsourcing Market Share by Country (2021-2032)
Figure 48. Australia Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. China Taiwan Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. South America Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. South America Clinical Trials Outsourcing Market Share by Country (2021-2032)
Figure 53. Brazil Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Argentina Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Chile Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Colombia Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 57. Peru Clinical Trials Outsourcing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 58. Charles River Laboratories Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 59. IQVIA Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 60. ICON PLC Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 61. Labcorp Drug Development Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 62. Syneos Health Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 64. Wuxi AppTec Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 65. Parexel Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 66. Advanced Clinical Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 67. BioAnalytix Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 68. Curia Global Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 69. CMED Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 70. Cromos Pharma Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 71. Criterium Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 72. KCR S.A. Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 73. Medpace Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 74. Medelis Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 75. OCT Group Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 76. ProTrials Research Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 77. PROMETRIKA Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 78. Quality Data Service Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 79. QPS Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 80. Sofpromed Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 81. Veristat Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Figure 82. Worldwide Clinical Trials Revenue Growth Rate in Clinical Trials Outsourcing Business (2021-2026)
Scope & coverage.
Types
- Phase I
- Phase II
- Phase III
- Phase IV
Applications
- Cancer
- CVDs
- Infectious Diseases
- Musculoskeletal Diseases
- Nervous System Disorders
- Others
Companies covered
- Charles River Laboratories
- IQVIA
- ICON PLC
- Labcorp Drug Development
- Syneos Health
- Thermo Fisher Scientific
- Wuxi AppTec
- Parexel
- Advanced Clinical
- BioAnalytix
- Curia Global
- CMED
- Cromos Pharma
- Criterium
- KCR S.A.
- Medpace
- Medelis
- OCT Group
- ProTrials Research
- PROMETRIKA
- Quality Data Service
- QPS
- Sofpromed
- Veristat
- Worldwide Clinical Trials
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Clinical Trials Outsourcing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Phase I
- 2.2.3 Phase II
- 2.2.4 Phase III
- 2.2.5 Phase IV
- 2.3 Clinical Trials Outsourcing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cancer
- 2.3.3 CVDs
- 2.3.4 Infectious Diseases
- 2.3.5 Musculoskeletal Diseases
- 2.3.6 Nervous System Disorders
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Clinical Trials Outsourcing Breakdown Data by Type
- 3.1 Global Clinical Trials Outsourcing Historic Market Size by Type (2021-2026)
- 3.2 Global Clinical Trials Outsourcing Forecasted Market Size by Type (2027-2032)
4 Clinical Trials Outsourcing Breakdown Data by Application
- 4.1 Global Clinical Trials Outsourcing Historic Market Size by Application (2021-2026)
- 4.2 Global Clinical Trials Outsourcing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Clinical Trials Outsourcing Market Perspective (2021-2032)
- 5.2 Global Clinical Trials Outsourcing Growth Trends by Region
- 5.2.1 Global Clinical Trials Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Clinical Trials Outsourcing Historic Market Size by Region (2021-2026)
- 5.2.3 Clinical Trials Outsourcing Forecasted Market Size by Region (2027-2032)
- 5.3 Clinical Trials Outsourcing Market Dynamics
- 5.3.1 Clinical Trials Outsourcing Industry Trends
- 5.3.2 Clinical Trials Outsourcing Market Drivers
- 5.3.3 Clinical Trials Outsourcing Market Challenges
- 5.3.4 Clinical Trials Outsourcing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Clinical Trials Outsourcing Players by Revenue
- 6.1.1 Global Top Clinical Trials Outsourcing Players by Revenue (2021-2026)
- 6.1.2 Global Clinical Trials Outsourcing Revenue Market Share by Players (2021-2026)
- 6.2 Global Clinical Trials Outsourcing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Clinical Trials Outsourcing Head Office and Area Served
- 6.4 Global Clinical Trials Outsourcing Players, Product Type & Application
- 6.5 Global Clinical Trials Outsourcing Manufacturers Established Date
- 6.6 Global Clinical Trials Outsourcing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Clinical Trials Outsourcing Market Size (2021-2032)
- 7.2 North America Clinical Trials Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Clinical Trials Outsourcing Market Size by Country (2021-2026)
- 7.4 North America Clinical Trials Outsourcing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Clinical Trials Outsourcing Market Size (2021-2032)
- 8.2 Europe Clinical Trials Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Clinical Trials Outsourcing Market Size by Country (2021-2026)
- 8.4 Europe Clinical Trials Outsourcing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Clinical Trials Outsourcing Market Size (2021-2032)
- 9.2 Asia-Pacific Clinical Trials Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Clinical Trials Outsourcing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Clinical Trials Outsourcing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Clinical Trials Outsourcing Market Size (2021-2032)
- 10.2 South America Clinical Trials Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Clinical Trials Outsourcing Market Size by Country (2021-2026)
- 10.4 South America Clinical Trials Outsourcing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Clinical Trials Outsourcing Market Size (2021-2032)
- 11.2 Middle East & Africa Clinical Trials Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Clinical Trials Outsourcing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Clinical Trials Outsourcing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River Laboratories
- 12.1.1 Charles River Laboratories Company Information
- 12.1.2 Charles River Laboratories Business Overview
- 12.1.3 Charles River Laboratories Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.1.4 Charles River Laboratories Clinical Trials Outsourcing Product Portfolio
- 12.1.5 Charles River Laboratories Recent Developments
- 12.2 IQVIA
- 12.2.1 IQVIA Company Information
- 12.2.2 IQVIA Business Overview
- 12.2.3 IQVIA Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.2.4 IQVIA Clinical Trials Outsourcing Product Portfolio
- 12.2.5 IQVIA Recent Developments
- 12.3 ICON PLC
- 12.3.1 ICON PLC Company Information
- 12.3.2 ICON PLC Business Overview
- 12.3.3 ICON PLC Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.3.4 ICON PLC Clinical Trials Outsourcing Product Portfolio
- 12.3.5 ICON PLC Recent Developments
- 12.4 Labcorp Drug Development
- 12.4.1 Labcorp Drug Development Company Information
- 12.4.2 Labcorp Drug Development Business Overview
- 12.4.3 Labcorp Drug Development Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.4.4 Labcorp Drug Development Clinical Trials Outsourcing Product Portfolio
- 12.4.5 Labcorp Drug Development Recent Developments
- 12.5 Syneos Health
- 12.5.1 Syneos Health Company Information
- 12.5.2 Syneos Health Business Overview
- 12.5.3 Syneos Health Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.5.4 Syneos Health Clinical Trials Outsourcing Product Portfolio
- 12.5.5 Syneos Health Recent Developments
- 12.6 Thermo Fisher Scientific
- 12.6.1 Thermo Fisher Scientific Company Information
- 12.6.2 Thermo Fisher Scientific Business Overview
- 12.6.3 Thermo Fisher Scientific Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.6.4 Thermo Fisher Scientific Clinical Trials Outsourcing Product Portfolio
- 12.6.5 Thermo Fisher Scientific Recent Developments
- 12.7 Wuxi AppTec
- 12.7.1 Wuxi AppTec Company Information
- 12.7.2 Wuxi AppTec Business Overview
- 12.7.3 Wuxi AppTec Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.7.4 Wuxi AppTec Clinical Trials Outsourcing Product Portfolio
- 12.7.5 Wuxi AppTec Recent Developments
- 12.8 Parexel
- 12.8.1 Parexel Company Information
- 12.8.2 Parexel Business Overview
- 12.8.3 Parexel Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.8.4 Parexel Clinical Trials Outsourcing Product Portfolio
- 12.8.5 Parexel Recent Developments
- 12.9 Advanced Clinical
- 12.9.1 Advanced Clinical Company Information
- 12.9.2 Advanced Clinical Business Overview
- 12.9.3 Advanced Clinical Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.9.4 Advanced Clinical Clinical Trials Outsourcing Product Portfolio
- 12.9.5 Advanced Clinical Recent Developments
- 12.10 BioAnalytix
- 12.10.1 BioAnalytix Company Information
- 12.10.2 BioAnalytix Business Overview
- 12.10.3 BioAnalytix Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.10.4 BioAnalytix Clinical Trials Outsourcing Product Portfolio
- 12.10.5 BioAnalytix Recent Developments
- 12.11 Curia Global
- 12.11.1 Curia Global Company Information
- 12.11.2 Curia Global Business Overview
- 12.11.3 Curia Global Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.11.4 Curia Global Clinical Trials Outsourcing Product Portfolio
- 12.11.5 Curia Global Recent Developments
- 12.12 CMED
- 12.12.1 CMED Company Information
- 12.12.2 CMED Business Overview
- 12.12.3 CMED Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.12.4 CMED Clinical Trials Outsourcing Product Portfolio
- 12.12.5 CMED Recent Developments
- 12.13 Cromos Pharma
- 12.13.1 Cromos Pharma Company Information
- 12.13.2 Cromos Pharma Business Overview
- 12.13.3 Cromos Pharma Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.13.4 Cromos Pharma Clinical Trials Outsourcing Product Portfolio
- 12.13.5 Cromos Pharma Recent Developments
- 12.14 Criterium
- 12.14.1 Criterium Company Information
- 12.14.2 Criterium Business Overview
- 12.14.3 Criterium Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.14.4 Criterium Clinical Trials Outsourcing Product Portfolio
- 12.14.5 Criterium Recent Developments
- 12.15 KCR S.A.
- 12.15.1 KCR S.A. Company Information
- 12.15.2 KCR S.A. Business Overview
- 12.15.3 KCR S.A. Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.15.4 KCR S.A. Clinical Trials Outsourcing Product Portfolio
- 12.15.5 KCR S.A. Recent Developments
- 12.16 Medpace
- 12.16.1 Medpace Company Information
- 12.16.2 Medpace Business Overview
- 12.16.3 Medpace Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.16.4 Medpace Clinical Trials Outsourcing Product Portfolio
- 12.16.5 Medpace Recent Developments
- 12.17 Medelis
- 12.17.1 Medelis Company Information
- 12.17.2 Medelis Business Overview
- 12.17.3 Medelis Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.17.4 Medelis Clinical Trials Outsourcing Product Portfolio
- 12.17.5 Medelis Recent Developments
- 12.18 OCT Group
- 12.18.1 OCT Group Company Information
- 12.18.2 OCT Group Business Overview
- 12.18.3 OCT Group Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.18.4 OCT Group Clinical Trials Outsourcing Product Portfolio
- 12.18.5 OCT Group Recent Developments
- 12.19 ProTrials Research
- 12.19.1 ProTrials Research Company Information
- 12.19.2 ProTrials Research Business Overview
- 12.19.3 ProTrials Research Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.19.4 ProTrials Research Clinical Trials Outsourcing Product Portfolio
- 12.19.5 ProTrials Research Recent Developments
- 12.20 PROMETRIKA
- 12.20.1 PROMETRIKA Company Information
- 12.20.2 PROMETRIKA Business Overview
- 12.20.3 PROMETRIKA Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.20.4 PROMETRIKA Clinical Trials Outsourcing Product Portfolio
- 12.20.5 PROMETRIKA Recent Developments
- 12.21 Quality Data Service
- 12.21.1 Quality Data Service Company Information
- 12.21.2 Quality Data Service Business Overview
- 12.21.3 Quality Data Service Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.21.4 Quality Data Service Clinical Trials Outsourcing Product Portfolio
- 12.21.5 Quality Data Service Recent Developments
- 12.22 QPS
- 12.22.1 QPS Company Information
- 12.22.2 QPS Business Overview
- 12.22.3 QPS Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.22.4 QPS Clinical Trials Outsourcing Product Portfolio
- 12.22.5 QPS Recent Developments
- 12.23 Sofpromed
- 12.23.1 Sofpromed Company Information
- 12.23.2 Sofpromed Business Overview
- 12.23.3 Sofpromed Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.23.4 Sofpromed Clinical Trials Outsourcing Product Portfolio
- 12.23.5 Sofpromed Recent Developments
- 12.24 Veristat
- 12.24.1 Veristat Company Information
- 12.24.2 Veristat Business Overview
- 12.24.3 Veristat Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.24.4 Veristat Clinical Trials Outsourcing Product Portfolio
- 12.24.5 Veristat Recent Developments
- 12.25 Worldwide Clinical Trials
- 12.25.1 Worldwide Clinical Trials Company Information
- 12.25.2 Worldwide Clinical Trials Business Overview
- 12.25.3 Worldwide Clinical Trials Revenue in Clinical Trials Outsourcing Business (2021-2026)
- 12.25.4 Worldwide Clinical Trials Clinical Trials Outsourcing Product Portfolio
- 12.25.5 Worldwide Clinical Trials Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst